Charles Schwab’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-312,756
| Closed | -$36K | – | 3215 |
|
|
2018
Q4 | $36K | Sell |
312,756
-936,991
| -75% | -$108K | ﹤0.01% | 3137 |
|
|
2018
Q3 | $2.13M | Sell |
1,249,747
-62,283
| -5% | -$106K | ﹤0.01% | 2410 |
|
|
2018
Q2 | $2.28M | Buy |
1,312,030
+88,386
| +7% | +$154K | ﹤0.01% | 2335 |
|
|
2018
Q1 | $2.24M | Buy |
1,223,644
+172,236
| +16% | +$315K | ﹤0.01% | 2289 |
|
|
2017
Q4 | $2.35M | Buy |
1,051,408
+106,222
| +11% | +$237K | ﹤0.01% | 2250 |
|
|
2017
Q3 | $2.74M | Sell |
945,186
-35,368
| -4% | -$103K | ﹤0.01% | 2159 |
|
|
2017
Q2 | $4.36M | Buy |
980,554
+119,492
| +14% | +$532K | ﹤0.01% | 1888 |
|
|
2017
Q1 | $4.01M | Buy |
861,062
+82,163
| +11% | +$383K | ﹤0.01% | 1884 |
|
|
2016
Q4 | $4.74M | Buy |
778,899
+37,560
| +5% | +$229K | 0.01% | 1769 |
|
|
2016
Q3 | $4.09M | Buy |
741,339
+69,354
| +10% | +$382K | ﹤0.01% | 1775 |
|
|
2016
Q2 | $2.55M | Buy |
671,985
+321,611
| +92% | +$1.22M | ﹤0.01% | 1942 |
|
|
2016
Q1 | $968K | Buy |
350,374
+8,142
| +2% | +$22.5K | ﹤0.01% | 2360 |
|
|
2015
Q4 | $1.94M | Buy |
342,232
+33,129
| +11% | +$188K | ﹤0.01% | 2095 |
|
|
2015
Q3 | $1.64M | Sell |
309,103
-10,714
| -3% | -$56.8K | ﹤0.01% | 2179 |
|
|
2015
Q2 | $2.66M | Buy |
319,817
+10,426
| +3% | +$86.6K | ﹤0.01% | 1933 |
|
|
2015
Q1 | $1.43M | Buy |
309,391
+79,772
| +35% | +$369K | ﹤0.01% | 2235 |
|
|
2014
Q4 | $701K | Buy |
229,619
+34,770
| +18% | +$106K | ﹤0.01% | 2497 |
|
|
2014
Q3 | $543K | Buy |
194,849
+3,351
| +2% | +$9.34K | ﹤0.01% | 2556 |
|
|
2014
Q2 | $780K | Buy |
191,498
+13
| +0% | +$53 | ﹤0.01% | 2438 |
|
|
2014
Q1 | $1.02M | Buy |
191,485
+3,282
| +2% | +$17.4K | ﹤0.01% | 2278 |
|
|
2013
Q4 | $1.05M | Buy |
188,203
+25,138
| +15% | +$140K | ﹤0.01% | 2245 |
|
|
2013
Q3 | $742K | Buy |
163,065
+1
| +0% | +$5 | ﹤0.01% | 2363 |
|
|
2013
Q2 | $698K | Buy |
+163,064
| New | +$698K | ﹤0.01% | 2353 |
|